Thrivent Financial for Lutherans Purchases 759,799 Shares of Kenvue Inc. (NYSE:KVUE)

Thrivent Financial for Lutherans boosted its position in shares of Kenvue Inc. (NYSE:KVUE - Free Report) by 22.2% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,186,599 shares of the company's stock after acquiring an additional 759,799 shares during the period. Thrivent Financial for Lutherans owned 0.22% of Kenvue worth $96,836,000 as of its most recent SEC filing.

Several other hedge funds also recently bought and sold shares of KVUE. Riverview Trust Co purchased a new position in Kenvue in the 3rd quarter worth approximately $30,000. Ashton Thomas Securities LLC purchased a new stake in shares of Kenvue in the 3rd quarter valued at $35,000. Studio Investment Management LLC boosted its stake in shares of Kenvue by 52.1% in the 2nd quarter. Studio Investment Management LLC now owns 2,468 shares of the company's stock valued at $45,000 after purchasing an additional 845 shares in the last quarter. Deseret Mutual Benefit Administrators boosted its stake in shares of Kenvue by 49.7% in the 3rd quarter. Deseret Mutual Benefit Administrators now owns 1,960 shares of the company's stock valued at $45,000 after purchasing an additional 651 shares in the last quarter. Finally, Loring Wolcott & Coolidge Fiduciary Advisors LLP MA purchased a new stake in shares of Kenvue in the 2nd quarter valued at $61,000. Hedge funds and other institutional investors own 97.64% of the company's stock.

Wall Street Analyst Weigh In

KVUE has been the subject of a number of research reports. Deutsche Bank Aktiengesellschaft upped their price objective on shares of Kenvue from $23.00 to $24.00 and gave the company a "buy" rating in a research note on Wednesday, August 7th. JPMorgan Chase & Co. upped their price target on shares of Kenvue from $24.00 to $25.00 and gave the company an "overweight" rating in a report on Friday, October 11th. Jefferies Financial Group initiated coverage on shares of Kenvue in a report on Tuesday, September 24th. They set a "buy" rating and a $27.00 price target for the company. Piper Sandler upped their price target on shares of Kenvue from $20.00 to $21.00 and gave the company a "neutral" rating in a report on Monday, September 23rd. Finally, Royal Bank of Canada lowered shares of Kenvue from an "outperform" rating to a "sector perform" rating and set a $24.00 price target for the company. in a report on Tuesday, September 24th. One research analyst has rated the stock with a sell rating, seven have assigned a hold rating and four have given a buy rating to the company's stock. According to MarketBeat, the stock presently has an average rating of "Hold" and a consensus price target of $22.64.

Kenvue Stock Down 0.4 %

Shares of NYSE:KVUE traded down $0.09 during midday trading on Monday, reaching $23.73. The company's stock had a trading volume of 14,591,632 shares, compared to its average volume of 18,038,559. The firm has a 50 day moving average of $22.77 and a 200-day moving average of $20.71. The firm has a market capitalization of $45.50 billion, a P/E ratio of 43.24, a PEG ratio of 2.16 and a beta of 1.36. The company has a quick ratio of 0.69, a current ratio of 1.00 and a debt-to-equity ratio of 0.66. Kenvue Inc. has a 12-month low of $17.67 and a 12-month high of $24.13.

Kenvue (NYSE:KVUE - Get Free Report) last released its earnings results on Thursday, November 7th. The company reported $0.28 earnings per share for the quarter, topping analysts' consensus estimates of $0.27 by $0.01. The firm had revenue of $3.90 billion for the quarter, compared to the consensus estimate of $3.92 billion. Kenvue had a net margin of 6.88% and a return on equity of 21.43%. The company's revenue was down .4% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.31 EPS. On average, research analysts anticipate that Kenvue Inc. will post 1.07 earnings per share for the current year.

Kenvue Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, November 27th. Stockholders of record on Wednesday, November 13th will be given a $0.205 dividend. This represents a $0.82 dividend on an annualized basis and a dividend yield of 3.46%. The ex-dividend date of this dividend is Wednesday, November 13th. Kenvue's dividend payout ratio is presently 149.09%.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.